Accession Number ADA564152
Title Chemical Strategy to Translate Genetic/epigenetic Mechanisms to Breast Cancer Therapeutics.
Publication Date Jul 2012
Media Count 12p
Personal Author S. Ding
Abstract This project is designed to use a molecular signature strategy to develop new therapeutics against metastatic breast cancer. We have recently published this novel pathway-centric technology developed on a prostate cancer model (Li et al., 2012b). The goal for this project is to define a panel of genes that are tightly associated with breast cancer transition from initial epithelial morphology to mesenchymal-like cells. This process, known as the EMT transition, has been shown to play a critical role for breast cancer metastasis. Once the panel of EMT-linked is defined on a triple negative breast cancer, the next step is to conduct small molecular screens against such collection of responsive genes. Resulting candidate hits will be characterized on cell and animal models to determine their biological effects in inhibiting breast cancer metastasis to distal organs. This approach is uniquely suited to attack disease pathways in the absence of druggable targets that can be pursued by conventional approaches.
Keywords Breast cancer
Chemicals
Collection
Embryology
Epithelium
Genetics
Metastasis
Morphology
Prostate cancer
Response(Biology)


 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
57Q - Pharmacology & Pharmacological Chemistry
Corporate Author Army Medical Research and Materiel Command (Provisional), Fort Detrick, MD.
Document Type Technical report
Title Note Annual rept. 1 Jul 2011-30 Jun 2012.
NTIS Issue Number 1302
Contract Number W81XWH-11-1-0127

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader